• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

New mint on the block - Fresh hope for IBS treatment?

作者信息

Nakov Radislav, Heinrich Henriette

机构信息

Clinic of Gastroenterology, Tsaritsa Yoanna University Hospital, Medical University of Sofia, Sofia, Bulgaria.

St. Anna Spital, Luzern, Switzerland.

出版信息

United European Gastroenterol J. 2021 Nov;9(9):991-992. doi: 10.1002/ueg2.12166. Epub 2021 Nov 3.

DOI:10.1002/ueg2.12166
PMID:34730280
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8598954/
Abstract
摘要

相似文献

1
New mint on the block - Fresh hope for IBS treatment?领域新贵——肠易激综合征治疗的新希望？
United European Gastroenterol J. 2021 Nov;9(9):991-992. doi: 10.1002/ueg2.12166. Epub 2021 Nov 3.
2
Recent advances in the pharmacological management of constipation predominant irritable bowel syndrome.便秘主导型肠易激综合征的药理学治疗进展。
Expert Opin Pharmacother. 2020 Jan;21(1):73-84. doi: 10.1080/14656566.2019.1688784. Epub 2019 Nov 14.
3
Recent advances in pharmacological treatment of irritable bowel syndrome.肠易激综合征药物治疗的最新进展
World J Gastroenterol. 2014 Jul 21;20(27):8867-85. doi: 10.3748/wjg.v20.i27.8867.
4
Linaclotide, novel therapy for the treatment of chronic idiopathic constipation and constipation-predominant irritable bowel syndrome.利那洛肽，一种治疗慢性特发性便秘和便秘型肠易激综合征的新型疗法。
Adv Ther. 2013 Mar;30(3):203-11. doi: 10.1007/s12325-013-0012-9. Epub 2013 Feb 20.
5
Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.替加色罗用于治疗肠易激综合征和慢性便秘。
Cochrane Database Syst Rev. 2007 Oct 17(4):CD003960. doi: 10.1002/14651858.CD003960.pub3.
6
Current and emerging treatments for irritable bowel syndrome with constipation and chronic idiopathic constipation: focus on prosecretory agents.便秘型肠易激综合征和慢性特发性便秘的现有及新出现的治疗方法：聚焦于促分泌剂。
Pharmacotherapy. 2015 Jun;35(6):613-30. doi: 10.1002/phar.1594. Epub 2015 May 27.
7
Recommendations for pharmacologic management of IBS with constipation.肠易激综合征便秘型的药物治疗建议。
Ann Intern Med. 2022 Nov;175(11):JC122. doi: 10.7326/J22-0086. Epub 2022 Nov 1.
8
Tenapanor for constipation-predominant irritable bowel syndrome.替那帕诺用于以便秘为主的肠易激综合征。
Drugs Today (Barc). 2020 Mar;56(3):203-210. doi: 10.1358/dot.2020.56.3.3115214.
9
Constipation-predominant irritable bowel syndrome: a review of current and emerging drug therapies.便秘型肠易激综合征：当前及新出现的药物治疗综述
World J Gastroenterol. 2014 Jul 21;20(27):8898-909. doi: 10.3748/wjg.v20.i27.8898.
10
Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome.ROSE-010（一种胰高血糖素样肽-1 类似物）对以便秘为主的肠易激综合征女性患者胃肠道运动功能的影响。
Am J Physiol Gastrointest Liver Physiol. 2012 Jul;303(1):G120-8. doi: 10.1152/ajpgi.00076.2012. Epub 2012 Apr 19.

本文引用的文献

1
A trial-based economic evaluation of peppermint oil for the treatment of irritable bowel syndrome.一项基于试验的关于薄荷油治疗肠易激综合征的经济学评价。
United European Gastroenterol J. 2021 Nov;9(9):997-1006. doi: 10.1002/ueg2.12134. Epub 2021 Sep 1.
2
Peppermint Oil Treatment for Irritable Bowel Syndrome: A Randomized Placebo-Controlled Trial.薄荷油治疗肠易激综合征：一项随机安慰剂对照试验。
Am J Gastroenterol. 2021 Nov 1;116(11):2279-2285. doi: 10.14309/ajg.0000000000001395.
3
Comparing Costs and Outcomes of Treatments for Irritable Bowel Syndrome With Diarrhea: Cost-Benefit Analysis.比较腹泻型肠易激综合征治疗方法的成本和结果：成本效益分析。
Clin Gastroenterol Hepatol. 2022 Jan;20(1):136-144.e31. doi: 10.1016/j.cgh.2020.09.043. Epub 2020 Oct 1.
4
Efficacy of soluble fibre, antispasmodic drugs, and gut-brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis.可溶性纤维、抗痉挛药物和肠道-脑神经调节剂在肠易激综合征中的疗效：系统评价和网络荟萃分析。
Lancet Gastroenterol Hepatol. 2020 Feb;5(2):117-131. doi: 10.1016/S2468-1253(19)30324-3. Epub 2019 Dec 16.
5
Efficacy and Safety of Peppermint Oil in a Randomized, Double-Blind Trial of Patients With Irritable Bowel Syndrome.薄荷油治疗肠易激综合征的随机双盲试验的疗效和安全性。
Gastroenterology. 2020 Jan;158(1):123-136. doi: 10.1053/j.gastro.2019.08.026. Epub 2019 Aug 27.
6
Costs of irritable bowel syndrome in European countries with universal healthcare coverage: a meta-analysis.具有全民医保覆盖的欧洲国家肠易激综合征的成本：一项荟萃分析。
Eur Rev Med Pharmacol Sci. 2019 Apr;23(7):2986-3000. doi: 10.26355/eurrev_201904_17580.
7
Understanding symptom burden and attitudes to irritable bowel syndrome with diarrhoea: Results from patient and healthcare professional surveys.了解腹泻型肠易激综合征的症状负担及患者态度：患者与医疗保健专业人员调查结果
United European Gastroenterol J. 2018 Nov;6(9):1417-1427. doi: 10.1177/2050640618787648. Epub 2018 Jul 9.
8
Review article: the physiological effects and safety of peppermint oil and its efficacy in irritable bowel syndrome and other functional disorders.综述文章：薄荷油的生理作用和安全性及其在肠易激综合征和其他功能性疾病中的疗效。
Aliment Pharmacol Ther. 2018 Mar;47(6):738-752. doi: 10.1111/apt.14519. Epub 2018 Jan 26.
9
Irritable bowel syndrome diagnosis and management: A simplified algorithm for clinical practice.肠易激综合征的诊断与管理：一种适用于临床实践的简化算法。
United European Gastroenterol J. 2017 Oct;5(6):773-788. doi: 10.1177/2050640617731968. Epub 2017 Sep 28.
10
A novel role for TRPM8 in visceral afferent function.TRPM8 在内脏传入功能中的新作用。
Pain. 2011 Jul;152(7):1459-1468. doi: 10.1016/j.pain.2011.01.027. Epub 2011 Apr 13.